Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

Impulse control disorder during continuous subcutaneous apomorphine treatment (CAI) was recently reported. We describe a 54-year-old patient with familial Parkinson's disease, who after initiation of CAI in addition to high dose levodopa and amantadine, developed impulse control disorder (major financial loss related to risky transactions and self-medication), psychosis and depression, which lead up to attempted suicide. To our knowledge, this is the first case of attempted suicide under apomorphine treatment.


Walter Struhal, Michael Guger, Stephanie Hödl, Sok-Chu Ung, Michael Bach, Gerhard Ransmayr. Attempted suicide under high dose dopaminergic therapy including apomorphine. Wiener klinische Wochenschrift. 2012 Jul;124(13-14):461-3

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 22797806

View Full Text